MicroRNAs in cancer biology and therapy: Current status and perspectives
暂无分享,去创建一个
[1] V. Ambros,et al. The Cold Shock Domain Protein LIN-28 Controls Developmental Timing in C. elegans and Is Regulated by the lin-4 RNA , 1997, Cell.
[2] G. Ruvkun,et al. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans , 1993, Cell.
[3] M. Caligiuri,et al. Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] F. Kisseljov. MicroRNAs and cancer , 2014, Molecular Biology.
[5] C. Bloomfield,et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. , 2009, Blood.
[6] C. Croce. Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.
[7] John G Doench,et al. Comparison of siRNA-induced off-target RNA and protein effects. , 2007, RNA.
[8] C. Croce,et al. MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia , 2012, Oncotarget.
[9] M. Caligiuri,et al. miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts , 2010, Cell.
[10] Christopher J. Cheng,et al. The Duality of OncomiR Addiction in the Maintenance and Treatment of Cancer , 2012, Cancer journal.
[11] M. Neri,et al. miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[12] Yi Zhu,et al. Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non–small cell lung cancer , 2011, Chinese journal of cancer.
[13] A. Pasquinelli,et al. Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation , 2005, Cell.
[14] T. Speed,et al. A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression , 2014, Genes & development.
[15] C. Croce,et al. A new role for microRNAs, as ligands of Toll-like receptors , 2013, RNA biology.
[16] B. Cullen. Transcription and processing of human microRNA precursors. , 2004, Molecular cell.
[17] F. Su,et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells , 2011, Molecular Cancer.
[18] Joon Cheol Park,et al. Plasma components affect accuracy of circulating cancer-related microRNA quantitation. , 2012, The Journal of molecular diagnostics : JMD.
[19] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[20] T. Golub,et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations , 2008, Proceedings of the National Academy of Sciences.
[21] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[22] Kuan-Teh Jeang,et al. Identification of Small Molecules That Suppress MicroRNA Function and Reverse Tumorigenesis* , 2010, The Journal of Biological Chemistry.
[23] Jie Zhou,et al. microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling , 2010, Proceedings of the National Academy of Sciences.
[24] B. Xiao,et al. MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients , 2012, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[25] Michael Z Michael,et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.
[26] Quynh-Thu Le,et al. Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer. , 2010, Translational oncology.
[27] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[28] Konstantinos J. Mavrakis,et al. Cooperative control of tumor suppressor genes by a network of oncogenic microRNAs , 2011, Cell cycle.
[29] Hansjuerg Alder,et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. , 2009, Gynecologic oncology.
[30] Murat Gunel,et al. Sequence Variants in SLITRK1 Are Associated with Tourette's Syndrome , 2005, Science.
[31] Roberta Galli,et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response , 2012, Proceedings of the National Academy of Sciences.
[32] J. Sun,et al. EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers , 2011, Nature Medicine.
[33] H. Grosshans,et al. Repression of C. elegans microRNA targets at the initiation level of translation requires GW182 proteins , 2009, The EMBO journal.
[34] Ignace Vergote,et al. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers , 2012, Breast Cancer Research.
[35] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[36] Zhaohui Huang,et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer , 2010, International journal of cancer.
[37] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[38] E. Sontheimer,et al. Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.
[39] M. Caligiuri,et al. Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. , 2012, Blood.
[40] M. Kiriakidou,et al. An mRNA m7G Cap Binding-like Motif within Human Ago2 Represses Translation , 2007, Cell.
[41] Jinxiang Han,et al. Circulating microRNA-21 as noninvasive predictive biomarker for response in cancer immunotherapy. , 2013, Medical hypotheses.
[42] Naduparambil K Jacob,et al. Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation , 2014, Proceedings of the National Academy of Sciences.
[43] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[44] J. Stenvang,et al. The utility of LNA in microRNA-based cancer diagnostics and therapeutics. , 2008, Seminars in cancer biology.
[45] Doron Betel,et al. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. , 2009, Genes & development.
[46] Kevin Struhl,et al. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. , 2010, Molecular cell.
[47] M. Cleary,et al. The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression. , 2010, Cancer research.
[48] Ligang Wu,et al. MicroRNAs direct rapid deadenylation of mRNA. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[49] Akiko Iwasaki,et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[50] W. Filipowicz,et al. Inhibition of Translational Initiation by Let-7 MicroRNA in Human Cells , 2005, Science.
[51] Holger Sültmann,et al. Circulating miRNAs are correlated with tumor progression in prostate cancer , 2011, International journal of cancer.
[52] S. Kao,et al. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. , 2010, Oral diseases.
[53] M. Siomi,et al. Posttranscriptional regulation of microRNA biogenesis in animals. , 2010, Molecular cell.
[54] Ann M. Killary,et al. MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease , 2009, Cancer Prevention Research.
[55] J. Stenvang,et al. Inhibition of microRNA function by antimiR oligonucleotides , 2012, Silence.
[56] Yariv Yogev,et al. Serum MicroRNAs Are Promising Novel Biomarkers , 2008, PloS one.
[57] Terry Hyslop,et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation , 2008, The Journal of cell biology.
[58] Michael T. McManus,et al. Gene silencing in mammals by small interfering RNAs , 2002, Nature Reviews Genetics.
[59] Huanming Yang,et al. Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias. , 2009, Cancer research.
[60] S. Kauppinen,et al. LNA-mediated microRNA silencing in non-human primates , 2008, Nature.
[61] H. Iba,et al. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells , 2009, Nucleic acids research.
[62] Shu-Chun Lin,et al. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. , 2010, Oral oncology.
[63] M. Caligiuri,et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. , 2008, The New England journal of medicine.
[64] D. Ichikawa,et al. Circulating microRNAs in plasma of patients with gastric cancers , 2010, British Journal of Cancer.
[65] S. Guil,et al. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a , 2007, Nature Structural &Molecular Biology.
[66] K. Mimori,et al. Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases , 2012, British Journal of Cancer.
[67] B. Li,et al. Expression profiling reveals off-target gene regulation by RNAi , 2003, Nature Biotechnology.
[68] Christopher J. Cheng,et al. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma , 2012, Proceedings of the National Academy of Sciences.
[69] J. Luk,et al. Circulating markers for prognosis of hepatocellular carcinoma. , 2013, Expert opinion on medical diagnostics.
[70] I. Ng,et al. Sequential alterations of microrna expression in hepatocellular carcinoma development and venous metastasis , 2012, Hepatology.
[71] E. Moss,et al. Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. , 2002, Developmental biology.
[72] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[73] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[74] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[75] Goutam Ghosh Choudhury,et al. miR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression. , 2012, Carcinogenesis.
[76] Anton J. Enright,et al. Zebrafish MiR-430 Promotes Deadenylation and Clearance of Maternal mRNAs , 2006, Science.
[77] C. Burge,et al. The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution , 2005, Science.
[78] V. Ambros. MicroRNA Pathways in Flies and Worms Growth, Death, Fat, Stress, and Timing , 2003, Cell.
[79] Baorui Liu,et al. Cell-Free MicroRNA Expression Profiles in Malignant Effusion Associated with Patient Survival in Non-Small Cell Lung Cancer , 2012, PloS one.
[80] T. Tuschl,et al. Identification of Novel Genes Coding for Small Expressed RNAs , 2001, Science.
[81] Shigeyuki Yokoyama,et al. Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system. , 2007, Genes & development.
[82] Noam Shomron,et al. Downregulation of Mir-31, Mir-155, and Mir-564 in Chronic Myeloid Leukemia Cells , 2012, PloS one.
[83] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[84] J. Castle,et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.
[85] Xi Chen,et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. , 2011, European journal of cancer.
[86] D. Ichikawa,et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma , 2011, British Journal of Cancer.
[87] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[88] Christian Langer,et al. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[89] Yanjie Lu,et al. A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference , 2009, Nucleic acids research.
[90] Kimberly Walter,et al. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. , 2010, Cancer research.
[91] Matthias W. Hentze,et al. Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation , 2007, Nature.
[92] C. Croce,et al. Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2 , 2013, Proceedings of the National Academy of Sciences.
[93] Jiwang Zhang,et al. Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia. , 2012, Cancer cell.
[94] W. Gerald,et al. Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.
[95] Khaled Greish,et al. Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines , 2007, Journal of drug targeting.
[96] C. Croce,et al. MicroRNAs in Cancer. , 2009, Annual review of medicine.
[97] L. Lim,et al. An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans , 2001, Science.
[98] Brigitte Rack,et al. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer , 2010, Breast Cancer Research.
[99] K. J. Sweeney,et al. MicroRNAs as Novel Biomarkers for Breast Cancer , 2009, Journal of oncology.
[100] M. Behlke,et al. Chemical modification and design of anti-miRNA oligonucleotides , 2011, Gene Therapy.
[101] Xi Chen,et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[102] J. Steitz,et al. Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation , 2007, Science.
[103] M. Caligiuri,et al. Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. , 2010, Cancer cell.
[104] Xiao-guang Liu,et al. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer , 2012, Medical Oncology.
[105] A. Harris,et al. Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.
[106] D. Bartel,et al. The impact of microRNAs on protein output , 2008, Nature.
[107] Sung-Chou Li,et al. Aberrant expression of miR‐196a in gastric cancers and correlation with recurrence , 2012, Genes, chromosomes & cancer.
[108] Duan Ma,et al. The cell growth suppressor, mir-126, targets IRS-1. , 2008, Biochemical and biophysical research communications.
[109] Sandra B. Munro,et al. Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray , 2009, PloS one.
[110] M. Bissonnette,et al. The Microbe-Derived Short Chain Fatty Acid Butyrate Targets miRNA-Dependent p21 Gene Expression in Human Colon Cancer , 2011, PloS one.
[111] E. Izaurralde,et al. GW182 interaction with Argonaute is essential for miRNA-mediated translational repression and mRNA decay , 2008, Nature Structural &Molecular Biology.
[112] M. Stoffel,et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs , 2007, Nature Biotechnology.
[113] C. Croce,et al. The role of microRNA genes in papillary thyroid carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[114] C. Croce,et al. Non‐coding RNAs in cancer initiation and progression and as novel biomarkers , 2011, Molecular oncology.
[115] Kishore Guda,et al. The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancers , 2008, Genes, chromosomes & cancer.
[116] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[117] Zejuan Li,et al. miR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia , 2012, Proceedings of the National Academy of Sciences.
[118] Xi Chen,et al. Identification of seven serum microRNAs from a genome‐wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas , 2013, International journal of cancer.
[119] Sota Asaga,et al. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. , 2011, Clinical chemistry.
[120] P. Bork,et al. mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. , 2006, Genes & development.
[121] E. Ng,et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.
[122] Min Liu,et al. miR‐181a mediates metabolic shift in colon cancer cells via the PTEN/AKT pathway , 2014, FEBS letters.
[123] Li Zhou,et al. Small RNAs have a large impact , 2012, RNA biology.
[124] T. Rana,et al. Silencing microRNA by interfering nanoparticles in mice , 2011, Nucleic acids research.
[125] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[126] G. Hannon,et al. Control of translation and mRNA degradation by miRNAs and siRNAs. , 2006, Genes & development.
[127] Phillip A. Sharp,et al. microRNAs: A Safeguard against Turmoil? , 2007, Cell.
[128] David I. K. Martin,et al. MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[129] Y Pawitan,et al. Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer , 2013, Oncogene.
[130] L. Cobiac,et al. Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR‐17‐92 cluster , 2013, Molecular carcinogenesis.
[131] K. Ghoshal,et al. TGFβ mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3 , 2009, Oncogene.
[132] Konstantinos J. Mavrakis,et al. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL) , 2011, Nature Genetics.
[133] Stefan Holdenrieder,et al. MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels , 2011, PloS one.
[134] C. Croce,et al. Role of microRNAs in lymphoid biology and disease , 2011, Current opinion in hematology.
[135] C. Croce,et al. MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation , 2012, Proceedings of the National Academy of Sciences.
[136] G. Nuovo,et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. , 2008, Biochemical and biophysical research communications.
[137] Taous Khan,et al. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. , 2010, Biochimica et biophysica acta.
[138] M. Caligiuri,et al. Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia , 2013, Clinical Cancer Research.
[139] William Ignace Wei,et al. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.
[140] Jerry Pelletier,et al. Short RNAs repress translation after initiation in mammalian cells. , 2006, Molecular cell.
[141] Takayuki Murata,et al. MicroRNA Inhibition of Translation Initiation in Vitro by Targeting the Cap-Binding Complex eIF4F , 2007, Science.
[142] Wei Gao,et al. Biomarkers for Use in Monitoring Responses of Nasopharyngeal Carcinoma Cells to Ionizing Radiation , 2012, Sensors.
[143] Xi Chen,et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. , 2010, Clinical chemistry.
[144] M. Fabbri. TLRs as miRNA receptors. , 2012, Cancer research.
[145] V. Ambros,et al. An Extensive Class of Small RNAs in Caenorhabditis elegans , 2001, Science.
[146] S. Lowe,et al. miR-19 is a key oncogenic component of mir-17-92. , 2009, Genes & development.
[147] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[148] Bo Liu,et al. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. , 2009, Lung cancer.
[149] Dong-Woo Lee,et al. miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. , 2012, Cancer letters.
[150] Donglin Cao,et al. Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia , 2010, Proceedings of the National Academy of Sciences.
[151] Edwin Wang,et al. Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers , 2007, Nucleic acids research.
[152] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[153] Ulus Atasoy,et al. Circulating microRNAs in breast cancer and healthy subjects , 2009, BMC Research Notes.
[154] Yang Yu,et al. Evidence that microRNAs are associated with translating messenger RNAs in human cells , 2006, Nature Structural &Molecular Biology.
[155] Aaron M. King,et al. Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma , 2012, British Journal of Cancer.
[156] N. Zeleznik-Le,et al. miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia , 2012, Nature Communications.
[157] N. Rajewsky,et al. Cell-type-specific signatures of microRNAs on target mRNA expression. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[158] Mark A. Kay,et al. Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.
[159] J. Marshall,et al. Tissue and Serum microRNAs in the KrasG12D Transgenic Animal Model and in Patients with Pancreatic Cancer , 2011, PloS one.
[160] Y. Gong,et al. Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis , 2011, Digestive Diseases and Sciences.
[161] Yang Yu,et al. Transforming growth factor β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM , 2010, Oncogene.
[162] C. Sheridan,et al. Gene therapy finds its niche , 2011, Nature Biotechnology.
[163] J. Rowley,et al. miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia–rearranged leukemia , 2013, Proceedings of the National Academy of Sciences.
[164] M. Kudo,et al. Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients , 2009, PloS one.
[165] Y. Pekarsky,et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. , 2006, Cancer research.
[166] N. Guo,et al. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer. , 2009, Cancer treatment reviews.
[167] Anwar Hossain,et al. Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA , 2006, Molecular and Cellular Biology.
[168] L. Hood,et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury , 2009, Proceedings of the National Academy of Sciences.